Efforts by the OTS community to combat SARS-CoV-2 and COVID-19

SARS-CoV-2 coronavirus spike protein under siegeПодробнее

Is SARS-COV-2 Becoming Weak?Подробнее

Dr. Angela Rasmussen: Demystifying COVID-19. The Science of SARS-CoV2 Epidemiology and TransmissionПодробнее

Coronavirus Epidemic Update 31: Mortality Rate, Cleaning Products, A More/Less Severe Virus Strain?Подробнее

Dr. Angela Rasmussen: Demystifying COVID-19. SARS-CoV2 Therapeutics and VaccinesПодробнее

Scale of Sars-Cov-2 immunity still unclear | COVID-19 SpecialПодробнее

Update on TRACE: A Scalable Community-Based Approach to Estimate Prevalence of SARS-CoV-2 InfectionПодробнее

Overcoming Regulatory Challenges and Building Community Trust for a SARS-CoV-2 VaccineПодробнее

Oligonucleotide Therapeutics: New Drugs That Could Stop COVID-19Подробнее

Module 3.5 - Public genome repositories for SARS-CoV-2Подробнее

What's the Difference Between SARS-CoV2 and COVID19?Подробнее

COVID-19 T-Cell Data: Mapping Out SARS- CoV-2 Antigen & T-Cell RepertoiresПодробнее

How forensic researchers track down the origins of SARS-CoV2 | COVID-19 SpecialПодробнее

Aptamer-Based Detection and Blocking of the SARS CoV-2 Spike Glycoprotein | Andrej Luptak, PhD | UCIПодробнее

SARS-CoV-2 UK variant: Does it matter?Подробнее

Sars-Cov-2/Covid-19 – the virus, the disease and the solutions | Ultan Power (QUB) | SCIПодробнее

Controlling SARS CoV-2 | UC San Diego Health COVID Grand RoundsПодробнее

Bruce Walker: "COVID-19 and the pandemic" (9/1/2020)Подробнее

COVID 19 Research Community Forum: RNA Therapeutics: Informational Drugs as Pandemic Response Tool.Подробнее